AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 2936269
Drug: Papaveretum 0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Papaveretum 0.4 mg/kg
Trial: 2936269
Drug: Hyoscine 0.008
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyoscine 0.008 mg/kg
Trial: 22395587
Drug: 8% and
RxNorm normalized name: SULFACETAMIDE SODIUM 80 mg in 1 mL / SULFUR 40 mg in 1 mL TOPICAL SUSPENSION [Sodium Sulfacetamide 8% and Sulfur 4%]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8% and 10% topical sulfur ointment applied for a single day (24 hours)
Trial: 22395587
Drug: 8% and
RxNorm normalized name: SULFACETAMIDE SODIUM 80 mg in 1 mL / SULFUR 40 mg in 1 mL TOPICAL SUSPENSION [Sodium Sulfacetamide 8% and Sulfur 4%]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8% and 10% topical sulfur ointment applied for three successive nights
Trial: 22395587
Drug: 8% and
RxNorm normalized name: SULFACETAMIDE SODIUM 80 mg in 1 mL / SULFUR 40 mg in 1 mL TOPICAL SUSPENSION [Sodium Sulfacetamide 8% and Sulfur 4%]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8% and 10% topical sulfur ointment applied for three successive days
Trial: 19965971
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of heparin and aspirin
Trial: 16735113
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate (FP) 100 micro g bd
Trial: 16735113
Drug: Budesonide (BUD)
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide (BUD) 200 micro g bd
Trial: 9863300
Drug: Beta-interferon (subcutaneous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-interferon (subcutaneous or intramuscular administration)
Trial: 8705152
Drug: Intranasal nitroglycerin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal nitroglycerin 0.3 mg
Trial: 8705152
Drug: Intranasal nitroglycerin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal nitroglycerin 0.5 mg
Trial: 8705152
Drug: Intranasal nitroglycerin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal nitroglycerin 0.75 mg
Trial: 8705152
Drug: Intranasal nitroglycerin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal nitroglycerin 1.0 mg
Trial: 7033016
Drug: Benzbromarone 100
RxNorm normalized name: benzbromarone 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benzbromarone 100 mg daily
Trial: 7033016
Drug: Probenecid 1000
RxNorm normalized name: probenecid 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Probenecid 1000 mg daily
Trial: 30794093
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy (CT) + Driving-based interactive video games (DBIVG)
Trial: 30794093
Drug: Conventional therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional therapy (CT) + Treadmill walking training
Trial: 2696020
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg iron daily
Trial: 31658725
Drug: 80 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg iron daily
Trial: 31658725
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg iron daily
Trial: 29202732
Drug: Targeted kyphosis-specific
RxNorm normalized name: Kyprolis
DrugBank: Carfilzomib (DB08889)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Targeted kyphosis-specific exercise and posture training program, delivered by a physical therapist, 1 hour, twice a week for 3 months.
Trial: 25324445
Drug: Paracetamol and
RxNorm normalized name: Paracetamol and tramadol only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol and ondansetron
Trial: 23887167
Drug: Hecolin (recombinant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hecolin (recombinant hepatitis E vaccine)
Trial: 21538380
Drug: VASP-guided clopidogrel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: VASP-guided clopidogrel maintenance doses
Trial: 21538380
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group with fixed clopidogrel doses
Trial: 11301563
Drug: BMS-188494 (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BMS-188494 (10 mg daily for 2 weeks)
Trial: 11301563
Drug: BMS-188494 (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BMS-188494 (25 mg daily for 4 weeks)
Trial: 11301563
Drug: BMS-188494 (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BMS-188494 (50 mg daily for 4 weeks)
Trial: 11301563
Drug: BMS-188494 (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BMS-188494 (100 mg daily for 4 weeks)
Trial: 11301563
Drug: BMS-188494 (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BMS-188494 (200 mg daily for 4 weeks)
Trial: 11301563
Drug: BMS-188494 (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BMS-188494 (all doses)
Trial: 2848876
Drug: Placebo (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (no active agents)
Trial: 16537882
Drug: Intrapleural fibrinolytic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrapleural fibrinolytic therapy
Trial: 11139755
Drug: NSAIDs (ibuprofen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NSAIDs (ibuprofen 400-800mg, naproxen 550-825mg, ketoprofen 50-75mg)
Trial: 11139755
Drug: Caffeine-containing preparations
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine-containing preparations of NSAIDs
Trial: 11139755
Drug: Relaxation therapies
RxNorm normalized name: Theraplex Eczema Therapy
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Relaxation therapies with EMG biofeedback and tricyclics
Trial: 11139755
Drug: Physical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical therapy and acupuncture
Trial: 8864328
Drug: Pantoprazole 240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pantoprazole 240 mg i.v. once daily for 7 days
Trial: 1623916
Drug: Loperamide oxide
RxNorm normalized name: Loperamide oxide
DrugBank: Loperamide oxide (DB14661)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loperamide oxide (1 to 16 mg)
Trial: 6391141
Drug: Levamisole (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levamisole (2.5 mg/kg twice weekly for 1 year)
Trial: 26825878
Drug: Liposomal Albendazole
RxNorm normalized name: Albendazole
DrugBank: Albendazole (DB00518)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Liposomal Albendazole (L‐ABZ), 10 mg/kg per day, p.o., b.i.d.
Trial: 26825878
Drug: Tablet-Albendazole (T‐ABZ),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tablet-Albendazole (T‐ABZ), 12-20 mg/kg per day, p.o., b.i.d.
Trial: 26825878
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (L‐ABZ and T‐ABZ)
Trial: 20578811
Drug: Tapentadol ER
RxNorm normalized name: tapentadol Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tapentadol ER 100 ‐ 250 mg b.i.d.
Trial: 20578811
Drug: Oxycodone CR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone CR 20 ‐ 50 mg b.i.d.
Trial: 12352272
Drug: Nicotine replacement
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotine replacement therapy (15-mg nicotine patch, 4-mg nicotine gum, 10-mg nicotine inhaler, or combination)
Trial: 7750335
Drug: Control (face‐mask
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (face‐mask oxygen therapy)
Trial: 2184356
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment (control group, n = 51)
Trial: 7292376
Drug: Prednisolone 20
RxNorm normalized name: prednisolone 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisolone 20 mg twice daily for three weeks
Trial: 31197389
Drug: Arthroscopic lateral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Arthroscopic lateral ligaments augmentation using suture-tape internal bracing (AST)
Trial: 27136907
Drug: Paliperidone palmitate
RxNorm normalized name: Paliperidone Palmitate
DrugBank: Paliperidone (DB01267)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paliperidone palmitate 100 mg eq. (156 mg of PP) administered via deltoid injections
Trial: 27136907
Drug: Paliperidone palmitate
RxNorm normalized name: Paliperidone Palmitate
DrugBank: Paliperidone (DB01267)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paliperidone palmitate 100 mg eq. (156 mg of PP) administered via gluteal injections
Trial: 21991738
Drug: Intra-articular corticosteroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-articular corticosteroid injection plus rehabilitation program
Trial: 12615585
Drug: Intravenous fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous fentanyl (1.5 micro g/kg)
Trial: 12615585
Drug: Nebulized fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Nebulized fentanyl (1.5 micro g/kg)
Trial: 10848718
Drug: Hydroxychloroquine (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydroxychloroquine (400 mg daily for 8 days)
Trial: 9313642
Drug: rTMS over
RxNorm normalized name: colloidal oatmeal
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rTMS over other positions (e.g. F3, F4, FCz, P3, P4)
Trial: 2878130
Drug: Overall treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overall treatment during the trial
Trial: 31350814
Drug: Purgenesis™ Day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Purgenesis™ Day Cream, Purgenesis™ Eye Cream, and Purgenesis™ Night Cream
Trial: 31350814
Drug: Prevage® Eye
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prevage® Eye Lotion, Prevage® Day Cream, and Prevage® Night Cream
Trial: 31350814
Drug: La Mer®
FDA approved: no
EMA approved: no
PMDA approved: no
Description: La Mer® Eye Balm, Crème de La Mer®, and La Mer® Night Cream
Trial: 29494818
Drug: Extended nodal
RxNorm normalized name: chlorpheniramine maleate / hydrocodone bitartrate / phenylephrine hydrochloride Oral Solution [Iodal HD]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended nodal irradiation (ENI) with two cycles of concurrent TP chemotherapy (paclitaxel 135 mg/m2 day 1 and cisplatin 20 mg/m2 days 1‐3, every 4 weeks) plus erlotinib (150 mg per day during chemoradiotherapy)
Trial: 29494818
Drug: Extended nodal
RxNorm normalized name: chlorpheniramine maleate / hydrocodone bitartrate / phenylephrine hydrochloride Oral Solution [Iodal HD]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended nodal irradiation (ENI) with two cycles of concurrent TP chemotherapy
Trial: 29494818
Drug: Conventional field
RxNorm normalized name: Field mushroom
DrugBank: Field mushroom (DB15605)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional field irradiation (CFI) with two cycles of concurrent TP chemotherapy plus erlotinib
Trial: 29494818
Drug: Conventional field
RxNorm normalized name: Field mushroom
DrugBank: Field mushroom (DB15605)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional field irradiation (CFI) with two cycles of concurrent TP chemotherapy
Trial: 24374549
Drug: Semuloparin 20
RxNorm normalized name: Semuloparin
DrugBank: Semuloparin (DB06294)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Semuloparin 20 mg commenced postoperatively
Trial: 24374549
Drug: Enoxaparin 40
RxNorm normalized name: ENOXAPARIN 40MG/0.4ML INJ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin 40 mg commenced preoperatively
Trial: 20602568
Drug: PEG +
RxNorm normalized name: Polyethylene glycol
DrugBank: Polyethylene glycol (DB09287)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PEG + Asc (2 l PEG + ascorbic acid)
Trial: 20602568
Drug: PEG (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PEG (4 l PEG solution)
Trial: 16633762
Drug: Intravenous propofol,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous propofol, fentanyl, and vecuronium anesthesia (TIVA, n = 30)
Trial: 16633762
Drug: Intravenous propofol,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous propofol, fentanyl, and vecuronium anesthesia (TIVA)
Trial: 11729013
Drug: 20 mg/day
RxNorm normalized name: futibatinib 20 mg/day (4 mg x 5) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg/day of paroxetine
Trial: 11729013
Drug: 40 mg/day
RxNorm normalized name: cabozantinib s-malate 140 mg/day (80 mg x 1-20 mg x 3/day) ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg/day of paroxetine
Trial: 3069498
Drug: Intra-arterial instillation
RxNorm normalized name: methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intra-arterial instillation of 0.5 mg reserpine
Trial: 19008680
Drug: Cognitive-linguistic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-linguistic treatment
Trial: 16785475
Drug: Abatacept (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abatacept (10 mg/kg body weight, once-monthly infusion)
Trial: 10955205
Drug: 7 treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7 treatment groups with different kinds of tutor modeling (whole word, letter-phoneme, combined whole word and letter-phoneme)
Trial: 8251355
Drug: Cetirizine 10
RxNorm normalized name: cetirizine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cetirizine 10 mg at night
Trial: 3513564
Drug: Oral metaproterenol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral metaproterenol
Trial: 3513564
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of inhaled and oral metaproterenol
Trial: 12854895
Drug: CHOP-HC (high
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CHOP-HC (high dose cyclophosphamide consolidation)
Trial: 10536557
Drug: rocuronium 0.9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rocuronium 0.9 mg kg‐1
Trial: 10536557
Drug: succinylcholine 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: succinylcholine 1.5 mg kg‐1
Trial: 30999196
Drug: TXA single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TXA single dose
Trial: 30999196
Drug: TXA two
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TXA two doses
Trial: 24346155
Drug: 80 mg
RxNorm normalized name: RNA 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg atorvastatin 12 hours and 40 mg atorvastatin 2 hours before PCI
Trial: 24346155
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg atorvastatin preoperatively for 7 days
Trial: 21685819
Drug: Ingestion of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ingestion of 25 mL of plain water before and every 5 min (DR)
Trial: 21685819
Drug: Mouth rinse
RxNorm normalized name: Ulcerease 0.6 % Mouth Rinse
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mouth rinse with 25 mL of plain water before and every 5 min (MR)
Trial: 17241841
Drug: Contraceptive counseling
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Contraceptive counseling with optional advance EC prescription
Trial: 12625668
Drug: Methyldopa 750‐4000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methyldopa 750‐4000 mg/day (n=34)
Trial: 12625668
Drug: No treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No treatment (n=36)
Trial: 1959195
Drug: Nisoldipine 5
RxNorm normalized name: nisoldipine 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nisoldipine 5 mg twice daily
Trial: 8829020
Drug: Isosorbide dinitrate
RxNorm normalized name: Isosorbide Dinitrate
DrugBank: Isosorbide dinitrate (DB00883)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide dinitrate 40 mg sustained-release
Trial: 30982761
Drug: Tamsulosin 0.4
RxNorm normalized name: tamsulosin 0.4 mg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamsulosin 0.4 mg daily for 5 days preoperatively, the morning of surgery, and the first postoperative day
Trial: 30982761
Drug: Placebo daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo daily for 5 days preoperatively, the morning of surgery, and the first postoperative day
Trial: 17522559
Drug: Intramuscular aripiprazole
RxNorm normalized name: Aripiprazole
DrugBank: Aripiprazole (DB01238)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Intramuscular aripiprazole
Trial: 20055763
Drug: Ropivacaine 2
RxNorm normalized name: fentanyl-ropivacaine 2 mcg/mL-0.1% injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine 2 mg/ml
Trial: 18726957
Drug: 5 ml
RxNorm normalized name: WATER,INHL 5 ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 ml lidocaine (group L)
Trial: 18726957
Drug: 5 ml
RxNorm normalized name: WATER,INHL 5 ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 ml lidocaine + 0.5 mg dinitrate isosorbide (group LN)
Trial: 15735447
Drug: Baseline pVL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baseline pVL >100,000 copies/mL
Trial: 27471314
Drug: Clonidine 1 µg·kg(‐1)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine 1 µg·kg(‐1)
Trial: 27471314
Drug: Clonidine 1 µg·kg(‐1)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine 1 µg·kg(‐1) and ketamine 1 mg·kg(‐1)
Trial: 22266895
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg oral clarithromycin twice daily for 5 months
Trial: 18039954
Drug: Valganciclovir 450
RxNorm normalized name: valganciclovir 450 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valganciclovir 450 mg orally twice daily
Trial: 18039954
Drug: Valaciclovir 500
RxNorm normalized name: valacyclovir 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valaciclovir 500 mg orally daily
Trial: 12126385
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg of hydrocodone/1000 mg of acetaminophen
Trial: 7741785
Drug: Test formulation
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test formulation (Analgin) containing 1 g of metamizole
Trial: 7741785
Drug: Reference formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference formulation containing 1 g of metamizole
Trial: 7741785
Drug: Test formulation
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test formulation (Analgin)
Trial: 1904450
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg single dose of melatonin
Trial: 1904450
Drug: 2.5 mg
RxNorm normalized name: biotin 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg melatonin in three divided doses (1 mg at 0800 hrs., 0.75 mg at 1000 and 1200 hrs.)
Trial: 30446762
Drug: Iron-folic acid
RxNorm normalized name: folic acid / iron carbonyl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron-folic acid (IFA) (FA, Fe 30 mg)
Trial: 30446762
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid alone (FA) (400 μg)
Trial: 22516321
Drug: MS Invigor8
RxNorm normalized name: MS-1819
DrugBank: MS-1819 (DB15004)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MS Invigor8 (Internet-based cognitive behavioural therapy self-management programme)
Trial: 14525749
Drug: Any analgesics
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Any analgesics accepted
Trial: 14525749
Drug: No analgesic
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No analgesic need
Trial: 14525749
Drug: Parenteral analgesics
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral analgesics accepted
Trial: 6337982
Drug: Inhaled atropine
RxNorm normalized name: atropine sulfate Inhalation Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled atropine (0.5 mg)
Trial: 6337982
Drug: Intravenous atropine
RxNorm normalized name: Atropine
DrugBank: Atropine (DB00572)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous atropine (0.5 mg)
Trial: 6337982
Drug: Inhaled and
RxNorm normalized name: Umeclidinium and Vilanterol Inhalation Powder
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled and intravenous placebos
Trial: 31507054
Drug: Statin therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statin therapy (specific dosage and duration not mentioned)
Trial: 31507054
Drug: Intermittent statin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent statin dosing, new LDL-lowering drugs, LDL apheresis, and supplements (specific details not mentioned)
Trial: 28118323
Drug: Chemotherapy (weekly
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy (weekly paclitaxel 80 mg/m² or four weekly pegylated liposomal doxorubicin 40 mg/m²)
Trial: 3051880
Drug: Tamoxifen (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen (40 mg daily)
Trial: 19447919
Drug: N-acetylcysteine (NAC)
DrugBank: Acetylcysteine (DB06151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: N-acetylcysteine (NAC) 1,200 mg/d
Trial: 16527576
Drug: BCG (six
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCG (six weekly instillations of 80 mg BCG [Tokyo 172 strain])
Trial: 16527576
Drug: Doxorubicin (17
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxorubicin (17 instillations of 20 mg doxorubicin)
Trial: 7790757
Drug: trapidil 200
RxNorm normalized name: trapidil 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: trapidil 200 mg tablets bid